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Abstract
Digital Image Elasto Tomography (DIET) is a non-invasive breast cancer screening
modality that induces mechanical vibrations into a breast and images its surface mo-
tion with digital cameras. A new approach in software based diagnosis of this surface
motion is presented, focussing on the second natural frequency of the breast. Sepa-
rate modal analysis is used to estimate the modal parameters using imaging data from
silicone phantoms. The second natural frequency proves to be a reliable metric with
the potential to clearly distinguish cancerous and healthy tissue as well as providing
an approximate location for the tumor. Furthermore, thorough statistical analysis is
performed to verify the results.
1 Introduction
Breast cancer is a major public health issue all over the world, with over a million women estimated
to be diagnosed with it every year, and more than 400,000 mortalities [1]. Statistics show that early
detection and intervention greatly increases five year survival rates to over 95% [2, 3], stressing the need
for effective wide-scale screening programmes.
X-ray mammography is currently the only approved large scale breast screening modality, being widely
used in most developed countries. However, mammography raises controversy due to low compliance,
poor sensitivity [4], accumulated radiation exposure [5], discomfort due to breast compression [6] and
over-diagnosis [7]. Furthermore, breast cancer screening programs are often not available in developing
countries due to relatively high costs involved [8] and rural populations with limited access to specialized
radiology clinics [9], requiring a low cost and less invasive modality to better meet screening demands.
The Digital Image Elasto Tomography (DIET) system is a breast cancer screening approach to detect
cancerous lesions based on a three dimensional representation of the elastic properties throughout the
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Figure 1: Schematic of the imaging principle in the DIET system.
breast volume. This technology is non-invasive, does not require breast compression, is very portable,
requires low operator skill (software based diagnosis) and is low in operational cost [10], rendering this
approach to be very suitable for large screening programs, particulary in remote areas or countries with
limited access to screening.
The DIET system makes use of the high contrast difference in elastic properties of 300–1500% between
cancerous tissue and healthy fatty or fibroglandular tissue in the breast [11], compared to a 5–10%
radio-density contrast imaged in X-ray mammography [2].
In the DIET system mechanical sinusoidal vibrations are applied to the breast and the resulting surface
oscillations are captured in three dimensions (3D) by an array of digital cameras surrounding the breast,
tracking fiducial markers on the breast’s surface [12, 13, 14], as shown in Figure 1. The surface vibration
response is analyzed to detect disturbances in the observed vibration patterns, indicating a higher stiffness
area within the tissue. This response is used to determine the probability and angular location of a
potentially cancerous inclusion. Finite element [12] (FEM) or surface based methods [10, 15] can be used
to provide an estimate of the location and the size of the inclusion. While FEM can provide a full 3D
elastographic map of the breast, the inverse solutions involved are typically computationally expensive
[16].
Surface based methods as in [10] show promising results and act as a proof of concept, but rely on a
visual inspection of the surface response at different imaging frequencies. The minimal modeling method
presented in [15] uses a broader range of imaging frequencies and fits a simple mechanical model to the
frequency response of the breast surface, providing a more automated software based diagnosis. This
concept has proven to be reliable for shallow tumors of 20 mm in diameter, but the analysis remains
inconclusive for smaller inclusions.
This research presents a concept to detect these smaller inclusions, using principles from modal analysis
theory, where the frequency response of a system with multiple degrees of freedom (MDOF) is considered
to be the summation of the frequency responses corresponding to each of its modes [17, 18]. Hypothesis
testing is used to detect significant changes in the modal parameters which could indicate the presence
of a tumor.
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Figure 2: (a) Silicone breast phantom with examples of the stiffer inclusions placed inside, (b) the
four locations (centrepoints in red) for the four tumor sizes (black circles), (c) tumor location B at the
6-o’clock position in the breast when viewed from the front.
2 Methodology
2.1 Experimental setup and data acquisition
This DIET tumor detection concept study is performed on a set of thirteen silicone gel phantom breasts
(A-341 Silicone, Factor2, Lakeside, USA) with comparable elastic properties to human tissue [10]. One
of these phantoms is ’healthy’, without any inclusions. The other twelve have inclusions of 5, 10 and 20
mm in diameter located at four different locations (depths) within the breast, all at a six-o’clock position
when viewed from the front, as can be seen in Figure 2.
Imaging of a breast is performed with the DIET clinical prototype. To enable robust tracking of the
surface motion, randomly placed colored fiducial markers are applied [14] as can also been seen in Figure
2. Prior to imaging, the cameras are calibrated and provide 3D motion data of every tracked marker
[14]. The tracked motion paths resemble an elliptical path in 3D-space. A sine curve, as in equation (1),
is fit to these paths to determine the amplitude A and phase φ in 3D for every marker’s displacement
x¯(t) [10],
x¯(t) = A¯ sin
(
ωt+ φ¯
)
(1)
where A¯ = [Ax, Ay, Az]
T
and φ¯ = [φx, φy, φz]
T
. Similar to the analysis in [15], this analysis uses the
displacement data in the direction of actuation, as characterized by Az and φz.
A spherical coordinate system is used to describe the location of the markers as shown in Figure 3. Angle
α is the elevation angle with 0◦ being at the chest wall and 90◦ at the nipple, and θ is the rotational
angle, starting with 0◦ at the 12-o’clock position when viewed from the front, rotating clockwise. To
account for uneven marker coverage, the surface of the breast in discretized into intervals of α and θ and
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Figure 3: Definition of angles α and θ. Angle α is the elevation angle with 0◦ being at the chest wall and
90◦ at the nipple, and θ is the rotational angle, starting with 0◦ at the 12-o’clock position when viewed
from the front, rotating clockwise.
Figure 4: A typical Bode diagram for one of the segments of an imaged breast showing the first two
natural frequencies.
the mean values of all tracked markers are used for each segment.
The silicone phantoms are imaged at frequencies between 10 and 40 Hz with a resolution of 1 Hz and
Bode diagrams of the frequency response with respect to the actuator are made, covering the first and
the second natural frequencies. A typical Bode diagram for one of the segments can be seen in Figure 4.
2.2 Modal parameter estimation
For a linear system with n DOF, the equations of motion are known to be
Mq¨(t) +Bq˙(t) +Kq(t) = f(t) (2)
where q(t) is the displacement vector of length n, f(t) the load vector of length n andM , B andK are n×n
mass, damping and stiffness matrices. Under the assumption of proportional damping, i.e. the condition
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KM−1B = BM−1K holds, equation (2) can be decoupled using the matrix of eigenmodes UO. By
substituting the coordinate transformation q(t) = UOp(t) in equation (2) followed by a premultiplication
with UO
T , the decoupled equations of motion result in:
UO
TMUOp¨(t) + UO
TBUOp˙(t) + UO
TKUOp(t) = UO
T f(t) (3)
When the matrix of eigenmodes UO is mass normalized, i.e. UO
TMUO = I, equation (3) transforms into
Ip¨(t) + 2ΞΩ0p˙(t) + Ω
2
0p(t) = UO
T f(t) (4)
where Ξ is a diagonal matrix with dimensionless modal damping factors ξk, and Ω0 is a diagonal matrix
with undamped natural frequencies ωOk.
Under the assumption of harmonic excitation and response and using the back-substitution of the coordi-
nate transformation q(t) = UOp(t), the frequency response matrix obtained from equation (4) becomes:
qˆ(ω) = UO
(−ω2I + 2jωΞΩ0 + Ω20)−1 UOT fˆ(ω)
=
n∑
k=1
uOkuOk
T
−ω2 + 2ξkωOkωj + ω2Ok
fˆ(ω) (5)
Now, in the case of a single-input-single-output (SISO) MDOF system, equation (5) reduces to a summa-
tion of single mass-spring-damper systems multiplied with a constant which is determined by the modes
of the system. As this tumor detection concept only takes the first two natural frequencies into account,
equation (5) can be written as
qˆ(ω) =
A1
−ω2 + 2ξ1ωO1ωj + ω2O1
+
A2
−ω2 + 2ξ2ωO2ωj + ω2O2
(6)
where A1 and A2 are constant multiplication factors determined by the eigenmodes of the system.
In this way, the problem of fitting the data in the Bode diagram in Figure 4 can be reduced and the data
can be split in two to fit each natural frequency independent from the other.
Quality of the model fits discussed, is objectively assessed by taking the root mean square (RMS)
deviation e of a fits magnitude, say Aˆ, compared to the magnitude of the measurement data, say A,
using n datapoints, defined by:
e =
√√√√ 1
n
n∑
i=1
(
Aˆi −Ai
)2
(7)
Fitting the two peaks at once proved to be hard using nonlinear least squares methods. Although the
model structure is capable of capturing the response as given in Figure 4, verified by manual parameter
estimation, these nonlinear least squares methods ended up in local minima or identified ’false’ peaks
due to noise in the data. A typical example of these bad fits is given in Figure 5, with an e-value of 0.66.
The two estimated natural frequencies for this segment are 19.2 and 22.4 Hz, where the first one is not
visible due to a very small gain. The 19.2 Hz frequency is obviously wrong and is probably triggered
by the noise in the data, finding a local minimum instead of a global minimum. To overcome this the
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Figure 5: Typical example of a problem with using a nonlinear least squares method. The two estimated
natural frequencies in this case are 19.2 and 22.4 Hz, where the first one is not visible due to a very small
gain. This effect is probably triggered by the noise in the data.
problem, the data is split into two parts and is fitted independently.
First, the end of the first peak is determined, under the assumption that the end of this peak is charac-
terized by a local minimum in the magnitude and a phase of 180◦. Robustness margins are incorporated
to ensure reliable results with noisy data.
The fitting procedure as described in [15] is used to determine the first natural frequency ωO1 and the
corresponding modal damping factor ξ1, using data up to the end of the first peak. This method proved
to be very robust and reliable.
The second natural frequency is fitted using the data for frequencies larger than the first natural frequency
ωO1. Here, the entire model structure as in equation (6) is used to assure a good match in phase. This
produces reliable results for the second natural frequency and corresponding damping factor. The first
natural frequency is estimated wrongly, because only the downward slope of the first peak is ’visible’
to the fitting procedure. By combining the results from the two fitting procedures, good and reliable
fits are obtained with e-values of approximately 0.2, allowing further analysis on the modal parameters,
especially the second natural frequency ωO2, which proves to be a reliable metric to detect tumor location.
2.3 Statistical analysis
The analysis is performed with 18 segments in θ-direction and 7 segments in α-direction, moving from
15◦ to 45◦ to exclude misfits around the actuator and around the chest wall. The actuator and the
chest wall disturb the surface motion of the breast yielding a different type of response. Increasing the
number of segments might give a higher resolution, but also increases the chance of gaps in the data due
to gaps in the fiducial marker coverage. Figure 6 shows an example of the used segments overlayed upon
a triangulation of the tracked fiducial markers.
To analyze and detect any significant changes of this metric within the breast, statistical hypothesis
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Figure 6: An example of the used segments overlayed upon a triangulation of the tracked fiducial markers.
testing is applied. The segments of the breast are divided into two groups. The first group includes all
segments within a 60◦ range in θ-direction. The second group consists of all the other segments. This is
repeated for all 18 θ-segments.
A two-sample t-test is used to compare both groups, where the null hypothesis is that both groups are
from the same normal distributions with equal means and unequal variances. The alternative hypothesis
is that the first group is from a different normal distribution with a lower mean value. An α-level of 0.01
is chosen, indicating a 99% confidence rate.
To furthermore assess statistical significance, the probability of obtaining the data in the analyzed
segment or lower, assuming that the null hypothesis indeed is true, is calculated and is called the p-value
of the test. A segment with a low p-value, specifically a p-value below the α-level, indicates a signifact
lower second natural frequency in that section.
3 Results
The method discussed above is applied to all thirteen silicone phantoms. Figure 7 shows a typical
example of the fitting procedure. Separate fits for the first and second natural frequency are shown and
their sum produces a close match to the original measurement data.
In Figure 8 as segmented breast when viewed from the front, is overlayed with a colormap of the first
natural frequency ωO1 for phantom B20 as indicated in Figure 2b. The gaps in the colormap represent
bad model fits due to noise and gaps in the data. At the tumor location (6-o’clock position) an area
with a significant higher first natural frequency is clearly visible, with an increase of about 3 Hz. This is
the effect as reported in [15]. This distinctive behavior occurs in all phantoms with tumors that are 20
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Figure 7: A typical example of the fitting results. Measurement data in dashed black, fit of the first
natural frequency in dash-dotted red, fit of the second natural frequency in dotted magenta and the
combined fit in solid blue.
mm in diameter.
In the healthy phantom, shown in Figure 9, the clear distinctive behavior is not present, but only a slight
gradual variation of about 1 Hz is visible. In the phantoms with smaller tumors, for instance phantom
B10 as shown in Figure 10, no distinctive behavior can be found and the results are similar to the healthy
case, with a 1 Hz gradual variation. The first natural frequency is analyzed for all phantoms and the
results can be found in Figures 16–28 in Appendix A.
Figure 11 shows the second natural frequency ωO2. The analyzed phantom in this case is B10 as indicated
in Figure 2b. At the 6-o’clock position, an area with a smaller second natural frequency is clearly visible.
Similar effects are visible in all phantoms with 10 and 20 mm tumors. These effects are not visible in
the phantoms without inclusion and in the phantoms with 5 mm tumors. Figures 29–41 in Appendix B
show the second natural frequency ωO2 for all analyzed phantoms.
To analyze the differences in the second natural frequency objectively, Figure 12 shows the probability
density functions for the normal distributions in two different segments of the breast, again for a B10
phantom. The black lines represent the distributions for the range 300◦ < θ < 360◦ (top of the breast)
and the red lines represent the distribution for the range 160◦ < θ < 220◦ around the location of the
tumor. The solid lines represent the data in the given ranges, the dashed lines correspond to all the data
outside this range. Clearly, the data with 160◦ < θ < 220◦ (solid red) has a different mean than the data
outside this region (dashed red). In the second case, the two distributions corresponding to the data
within the 300◦ < θ < 360◦ range (solid black) and the data outside this range (dashed black), show a
great amount of overlap.
To further verify these results, Figure 13 shows the result of the statistical t-test. The red area (value
1) is the area where the null hypothesis is rejected, indicating a lower second natural frequency with a
99% confidence level. The average p-value in the red area equals 6.486 · 10−7, while the average p-value
outside this area yields 0.8521.
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Figure 8: Segmented breast when viewed from the front with a colormap of the first natural frequency
ωO1 in [Hz] for a B20 silicone phantom as indicated in Figure 2b. Blank sections indicate bad model fits
due to noise and gaps in the data.
Figure 9: Segmented breast when viewed from the front with a colormap of the first natural frequency
ωO1 in [Hz] for a healthy silicone phantom.
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Figure 10: Segmented breast when viewed from the front with a colormap of the first natural frequency
ωO1 in [Hz] for a B10 silicone phantom as indicated in Figure 2b..
Figure 11: Segmented breast when viewed from the front with a colormap of the second natural frequency
ωO2 in [Hz] for a B10 silicone phantom as indicated in Figure 2b. Blank sections indicate bad model fits
due to noise and gaps in the data.
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Figure 12: Probability density functions for the normal distributions in two different segments of the
breast of a B10 phantom. The solid red line represents the data in the segment 160◦ < θ < 220◦ and
the dashed red line corresponds to data outside this segment. Similar, the solid black line show data in
the segment 300◦ < θ < 360◦ where the dashed black line considers the data outside this range.
(a) (b)
Figure 13: Result of the t-test for the B10 phantom, overlayed on the segmented breast. The metric
1− p is shown on the left (a), such that dark red resembles a low p-value and possibly a tumor. The test
outcome is given on the right (b), where the red area indicates rejection of the stated null hypothesis,
indicating a lower second natural frequency and thus a stiffer inclusion, and the blue area represents
acceptance of the null hypothesis.
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Table 1: Results of the t-test in terms of p-values for all thirtheen segment. A comparison is made between
the area where the null hypothesis is rejected (e.g. red area in Figure 13b), possibly an indication for an
inclusion, and the area where the null hypothesis is accepted (e.g. blue area in Figure 13b).
Phantom:
Average p-value in
rejection area
Average p-value in
acceptance area
Healthy — 0.50653
A5 4.5213 · 10−4 0.67531
B5 1.6714 · 10−3 0.63221
C5 1.5228 · 10−3 0.57836
D5 7.4005 · 10−3 0.50929
A10 1.5059 · 10−3 0.89132
B10 6.7370 · 10−7 0.80685
C10 2.5711 · 10−3 0.68937
D10 3.7114 · 10−3 0.57493
A20 1.5344 · 10−3 0.72851
B20 1.5399 · 10−4 0.87132
C20 4.3793 · 10−4 0.66437
D20 2.2566 · 10−8 0.63102
For all thirtheen phantoms, the p-values in the area where the null hypothesis is rejected are compared
to the p-values in the area where the null hypothesis is accepted by taking the average p-value within
the stated areas. The results can be found in Table 1.
All discussed results show similar behavior in all phantoms with 10 and 20 mm tumors. Furthermore, the
’healthy’ phantom (t-test results shown in Figure 14) does not show this response. Results for the 5 mm
tumors remain inconclusive under this method. Figure 15 shows the results for phantom D5, yielding a
false positive. Figures 29–41 in Appendix B show the results of the t-test for all analyzed phantoms.
4 Discussion
The proposed method using the model in equation (6) produced good model fits. The model is able to
capture the frequency response data from the surface of the oscillating breast phantom. By splitting the
problem in two parts, the method as discussed in [15] can be used, which proves to be very robust and
reliable. The fitting of the second peak gives some problems for the segments close to the chest wall and
close to the actuator, but produces good fits in the other segments.
As described in [15] the first natural frequency is a reliable metric to detect tumors of 20 mm in diameter,
with significant behavior at the location of the tumor. However, for smaller inclusions, the results remain
inconclusive.
The second natural frequency identified over the surface of the breast shows a distinctive decrease around
the tumor location. For all phantoms with 10 and 20 mm inclusion, this distinctive behavior shows up
and it remains unseen in the phantom without any inclusions. Detection of a 10 mm inclusion, which
is clinically significant in a screening application [19], is possible with this method. Tumors of 5 mm
in diameter also show no clear distinctive behavior. Imaging the breast up to higher frequencies and
incorporating the third natural frequency might give conclusive results for even smaller inclusions, thus
being a lead for future research.
12
(a) (b)
Figure 14: Result of the t-test for the healthy phantom, overlayed on the segmented breast. The metric
1− p is shown on the left (a), such that dark red resembles a low p-value and possibly a tumor. The test
outcome is given on the right (b), where the blue area represents acceptance of the null hypothesis. In
this case, no rejection is present, indicating no inclusions.
(a) (b)
Figure 15: Result of the t-test for the B10 phantom, overlayed on the segmented breast. The metric 1−p
is shown on the left (a), such that dark red resembles a low p-value and possibly a tumor. Notice that
in this case, two areas with low p-values show up. The test outcome is given on the right (b), where the
red area indicates rejection of the stated null hypothesis, and the blue area represents acceptance of the
null hypothesis. Only one of the two areas with low p-values is low enough to reject the null hypothesis.
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The distinctive behavior is verified by statistical analysis, with a less than 1% change that this behavior
is not caused by a stiffer inclusion, but by chance. The fact that the results are consistent for all 10 and
20 mm inclusions further indicates that the results are not coincidental.
For some of the phantoms, the identified inclusion area shows a deviation with the exact tumor location.
This is a known effect and is caused by assymetrical imaging of the particular phantom. FEM simulations
of exactly the same situation (mesh based on measured surface points of the phantom) show a similar
deviation in the disturbance of the motion data. Deviations up to 45◦ are considered to be acceptable.
Furthermore, in the outcome of the t-test a difference in size of the region where the null hypothesis is
rejected, is notable. Presumably, this effect can be a further lead for the location of the tumor inside the
breast in terms of distance from the surface. Phantoms D10 and D20, closest to the analyzed part of
the surface, show smaller regions of rejectance, which might be caused by a very localized effect due to
an inclusion which is very close to the surface and thus not affecting large areas of this surface. Tumors
deeper inside the breast show larger regions of rejectance, possibly due to the fact that deeper tumors
affect larger areas on the surface of the breast. Further research is necessary to assess the validity of this
phenomenon, both in vitro and in vivo.
This analysis only uses the surface motion in the direction of actuation. However, the surface of the
breast moves in 3D-space. Therefore, multidimensional models might be useful to further enhance the
tumor detection algorithm for the DIET system.
Overall, the concept needs further in vivo research to validate the results in real, human breasts. It
is expected that there is a limit on the tumor size that can be detected with the DIET system, but
manual analysis on the measurement data shows small disturbances in the measurement data for the
5 mm tumors. Further research should focus on finding automated analysis algorithms to detect these
smaller inclusions.
5 Conclusion
The presented approach is capable of detecting any tumors of 10 mm in diameter in larger in silicone
phantoms in an objective and repeatable way and is computationally inexpensive, especially when com-
pared to inverse finite element analysis. When in vivo validation yields similar results, the presented
method can be used to detect the existence and approximate location of a stiffer inclusion. This method
provides software based diagnosis without any human intervention, yielding low operator skill require-
ments. Combined with the DIET system, this approach could provide a reliable screening modality,
complementary to mammography and other currently used screening techniques.
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A First natural frequecny for all thirtheen phantoms
Figures 16–28 show the first natural frequency ωO1 for the indicated phantom. The gaps in the colormap
represent bad model fits due to noise and gaps in the data.
Figure 16: First natural frequency ωO1 in [Hz] for a healthy phantom.
Figure 17: First natural frequency ωO1 in [Hz] for a A5 phantom.
Figure 18: First natural frequency ωO1 in [Hz] for a B5 phantom.
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Figure 19: First natural frequency ωO1 in [Hz] for a C5 phantom.
Figure 20: First natural frequency ωO1 in [Hz] for a D5 phantom.
Figure 21: First natural frequency ωO1 in [Hz] for a A10 phantom.
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Figure 22: First natural frequency ωO1 in [Hz] for a B10 phantom.
Figure 23: First natural frequency ωO1 in [Hz] for a C10 phantom.
Figure 24: First natural frequency ωO1 in [Hz] for a D10 phantom.
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Figure 25: First natural frequency ωO1 in [Hz] for a A20 phantom.
Figure 26: First natural frequency ωO1 in [Hz] for a B20 phantom.
Figure 27: First natural frequency ωO1 in [Hz] for a C20 phantom.
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Figure 28: First natural frequency ωO1 in [Hz] for a D20 phantom.
B Analysis on the second natural frequency for all thirtheen
phantoms
The results of the analysis on the second natural frequency for all thirteen phantoms are shown below
in Figures 29–41. Tumor size and position is given corresponding to Figure 2b. All figures on the left
show the second natural frequency ωO2 for the indicated phantom. The gaps in the colormap represent
bad model fits due to noise and gaps in the data. The figures on the right show the result of the t-test.
Here, red areas indicate rejection of the null hypothesis, presumably due to a stiffer inclusion. Blue areas
indicate acceptance of the null hypothesis.
(a) (b)
Figure 29: Results for a healthy phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
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(a) (b)
Figure 30: Results for a A5 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the t-test
where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 31: Results for a B5 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the t-test
where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 32: Results for a C5 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the t-test
where red indicates rejection and blue indicates acceptance of the null hypothesis.
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(a) (b)
Figure 33: Results for a D5 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the t-test
where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 34: Results for a A10 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 35: Results for a B10 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
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(a) (b)
Figure 36: Results for a C10 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 37: Results for a D10 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 38: Results for a A20 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
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(a) (b)
Figure 39: Results for a B20 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 40: Results for a C20 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
(a) (b)
Figure 41: Results for a D20 phantom; (a) Second natural frequency ωO2 in [Hz], (b) result of the
t-test where red indicates rejection and blue indicates acceptance of the null hypothesis.
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